type here...

CATEGORIES

Breaking Research

LATEST

1234Page 1 of 4

TRENDING

EDITORS CHOICE

Achieve Life Sciences Announces Statistically Significant Smoking Cessation Results in Phase 3 ORCA-2 Clinical Trial of Cytisinicline in Adult Smokers

Medika Life -
Clinical results in primary and secondary endpoints for 6- and 12-week experimental smoking cessation treatment reported by company sponsor.

Teaming Up Two Biotech Winners to Fight Cancer: CRISPR and CAR T

William Haseltine, PhD -
Advances in CAR T, a remarkable immunotherapy treatment dubbed a “living drug.” This new therapy genetically modifies a patient’s cells to fight cancer, but current research efforts hope to treat autoimmune diseases, organ damage and more.

Got Cancer? Supplements May Be Dangerous

Michael Hunter, MD -
IF YOU HAVE CANCER, there is a reasonable chance that you are taking supplements. The use of dietary supplements in the United States is widespread....

CAR T-mRNA Therapy For Cardiac Fibrosis: A New Way Forward

William Haseltine, PhD -
This is a series on the advances in CAR T, a remarkable immunotherapy treatment dubbed a “living drug.” This new therapy genetically modifies a patient’s cells to fight cancer, but current research efforts hope to treat autoimmune diseases, organ damage and more.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories